Nine more new products have been classed as 'Drugs for which Discount is Not Deducted' (DND) from 1 July 2022, announced Department of Health and Social
Care (DHSC).
This takes the total number of products granted DND status over the past 2 years to over 500 following checks made by the Pharmaceutical Services Negotiating
Committee.
The Committee had made an application to DHSC and NHSBSA for the following 9 products to be added to the DND list of Individual items to which the discount
deduction scale will no longer apply from July 2022:
Fludrocortisone 50micrograms/5ml oral suspension (Group)
Lorazepam 1mg/5ml oral suspension (Group)
Lorazepam 500micrograms/5ml oral suspension (Group)
Zopiclone 3.75mg/5ml oral solution (Group)
Zopiclone 7.5mg/5ml oral solution (Group)
GA explore5 oral powder 12.5g sachets
HCU explore5 oral powder 12.5g sachets
MSUD explore5 oral powder 12.5g sachets
TYR explore5 oral powder 12.5g sachets
The DND list is updated monthly by the DHSC and includes grouped and individual items. Individual items are separately listed in Part II of the Drug Tariff.
Many of us know that oral health plays a hugely important role in our general health and wellbeing. We're continuing to see a rise of cosmetic dentistry
such as veneers and teeth whitening[1] but fundamentally, it shouldn't be forgotten that oral health encompasses so much more than aesthetics. Our diets,
the oral hygiene products we are using, and our brushing techniques are all elements that impact our oral health.
It's been hard to miss in the news that there is a dental crisis in the UK, with 'dental deserts' leaving some areas with over 3,000 patients for every NHS
dentist[2]. With oral health being of such importance to our overall health[3], it's only reiterated to us at Haleon that we must continue to promote access
to dental care and understanding of better dental health.
As I've mentioned in previous articles for Pharmacy Business, an understanding of preventative, self-care is hugely beneficial, not just to improve health
inclusivity but to help reduce these current burdens on both healthcare and dentistry professionals. We know that at Haleon, we, and the consumer healthcare
industry as a whole, have a responsibility to empower people to equip themselves with the tools and information to participate in their own and loved ones'
health - and dental health is such an important part of that.
The Department of Health and Social Care (DHSC) has issued a medicine supply notification for Dioralyte oral rehydration sachets.
"Dioralyte oral rehydration sachets are expected to be in limited supply until late December 2022. St Mark's solution is available as an unlicensed special and can
support an uplift in demand," said DHSC.
"Kidderminster formula is available as an unlicensed special and can support a partial uplift in demand. As an alternative to the unlicensed specials, the individual
components can be purchased from community pharmacies and supermarkets or prescribed, but there have been intermittent supply issues with glucose powder."
Diluted apple juice has been reported to be a potential alternative to electrolyte maintenance fluids in children with mild gastroenteritis and minimal dehydration.
If there is currently no listing on dm+d for the imported product for prescribers to select using their prescribing systems an EPS prescription for unlicensed St
Mark's solution cannot be issued.
A newly licensed 1mg/ml Omeprazole Powder for Oral Suspension has been developed by Rosemont Pharmaceuticals to meet the special needs of babies from 1 to 12
months old who have gastro-oesophageal reflux disease (GORD). In infants, the symptoms of GORD can be particularly distressing for both the child and parent.
Previously, Rosemont Omeprazole Powder for Oral Suspension has been available in 2mg/ml and 4mg/ml strengths. However, the addition of the new 1mg/ml product
ensures that the needs of all patient groups with GORD are sufficiently met.
The Rosemont range of Omeprazole Powder for Oral Suspension products are the only PPIs (proton pump inhibitors) indicated for use in babies from 1 month to 1 year.
Symptoms of GORD in infants are usually resolved by 1 year of age1, so it is key that there is a licensed treatment option available for the 1 to 12 month patient
group.
A newly licensed 1mg/ml Omeprazole Powder for Oral Suspension has been developed by Rosemont Pharmaceuticals to meet the special needs of babies
from 1 to 12 months old who have gastro-oesophageal reflux disease (GORD). In infants, the symptoms of GORD can be particularly distressing for both the child
and parent.
Previously, Rosemont Omeprazole Powder for Oral Suspension has been available in 2mg/ml and 4mg/ml strengths. However, the addition of the new 1mg/ml product
ensures that the needs of all patient groups with GORD are sufficiently met.
The Rosemont range of Omeprazole Powder for Oral Suspension products are the only PPIs (proton pump inhibitors) indicated for use in babies from 1 month to
1 year. Symptoms of GORD in infants are usually resolved by 1 year of age1, so it is key that there is a licensed treatment option available for the 1 to 12 month
patient group.
Scientists are testing oral spray for weight loss. But how it will work? Oral spray can give you the feeling of fullness and help you to avoid overeating.
The purpose of this blog post is to provide a comprehensive overview of oral health probiotics, their benefits, and how to incorporate them into your daily routine to improve your dental health. Additionally, the blog post will also discuss the precautions and potential side effects associated with oral probiotics.
The Department of Health and Social Care (DHSC) has issued a medicine supply notification for Sulfasalazine 250mg in 5ml oral suspension sugar free;
Pilocarpine hydrochloride 4% eye drops; Fluticasone 50microgram / Salmeterol 25microgam (Combisal) pressurised metered dose inhaler (pMDI); and Dalteparin (Fragmin)
10,000units/1mL solution for injection ampoule on Wednesday (21 December).
"Sulfasalazine 250mg/5ml oral suspension sugar free is out of stock from w/c 19th December until early June 2023. Sulfasalazine 500mg non-enteric coated tablets
remain available
"IPS Pharma, Nova Labs, and Rokshaw have currently confirmed they can manufacturer sulfasalazine 250mg/5ml oral suspension," said DHSC.
Pilocarpine 4% eye drops are out of stock until w/c 26th December 2022. Alternative strengths of pilocarpine (1% and 2%) eye drops remain available and will be
able to support increased demand. Specials of pilocarpine 4% preservative free eye drops are available if the licensed alternatives are not suitable. For off-label
use of the 4% drops in the treatment of xerostomia (dry mouth) in palliative care, pilocarpine 5mg tablets are available and are licensed for this indication.
Maintaining good oral hygiene is one of the most important things you can do for your teeth and gums.
Healthy teeth not only enable you to look and feel good, they make it possible to eat and speak properly. Good oral health is important to your overall well-being.
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approving an oral therapy to treat
myelofibrosis patients with moderate to severe anaemia.
Myelofibrosis is a rare blood cancer that affects the body's normal production of blood cells, and the affected patients are likely to develop anaemia over the
course of the disease.
British drugmaker GSK, the manufacturer of the oral therapy known as momelotinib, said that it can be used to treat "both newly diagnosed and previously treated
myelofibrosis patients."
The medicine helps address disease-related splenomegaly (enlarged spleen) or symptoms in adult patients who are Janus kinase (JAK) inhibitor naïve or have been
treated with ruxolitinib, as stated by the company.
Nina Mojas, Senior Vice President of Oncology Global Product Strategy at GSK, said that receiving the positive CHMP opinion "is a significant step in bringing
momelotinib to patients in the EU with this difficult-to-treat blood cancer."
The American healthcare company, CVS Health, has decided to remove the cold and cough pills containing phenylephrine from the drug stores.
The following decision comes after the health regulator, the US Food and Drug Administration (FDA) determines the decongestant is ineffective towards flu if
taken orally.
However, when ingested in pill or tablet form, this ingredient fails to reach its destination from the stomach to the nasal passages.
CVS Health spokesperson told USA Today, "We are removing a small number of oral decongestant products that contain phenylephrine as the only active ingredient
from CVS Pharmacy stores but will continue offering many other oral cough and cold products to meet consumer needs."
They almost run more than 9,000 stores in the US whereas their rival, Walgreens has not yet taken the step to remove over-the-counter medications from their shelves.
The Scottish government has issued a circular to inform community pharmacy contractors that the Serious Shortage Protocol (SSP) for Clarithromycin 125mg/5ml
oral suspension, an antibiotic product, due to expire on 15 December 2023, has been extended until Friday 12 January 2024.
The extension is applicable to SSP053 which allows community pharmacists to substitute this product with Clarithromycin 250mg/5ml oral suspension for patients
presenting with an NHS or private prescription.
Scotland's chief pharmaceutical officer, Alison Strath, has advised health boards to spread this information to community pharmacy contractors on their
pharmaceutical lists and area pharmaceutical committees, as well as general practices.
Community pharmacists have been advised to review and familiarise themselves with the new end date for the noted SSP.
Apcalis Oral Jelly is a very powerful jelly which has become popular for curing the teething issues of sexual Dysfunction in men. This potent oral jelly boosts your sexual energy of men to a great extent and thus it removes all the problems associated with it. It is strong and works quickly in the body and provides great results in no time.
Kamagra 100mg Pills And Oral Jelly is one of the most effective and safe products for the treatment of ED. Know about Viagra Medicines Side Effects. Find out why Kamagra is better than other ED products. For all info, before u buy and side effects, check on http://kamagraseller.com/kamagra-100m... Kamagra Oral Jelly acts like Kamagra, but has some distinctive and unique features, such as new flavors and different dosage guidelines. But basically these two forms differ only in their intake - one is swallowed as a tablet, while the other is liquid.
Pfizer's oral Covid-19 therapy will be evaluated as a potential treatment for patients hospitalised with the illness in a major British trial, scientists said on Monday, as cases rise in some parts of the world.
The world's largest randomised study of potential medicines for Covid-19, dubbed the RECOVERY trial, will assess Paxlovid across hospitals in Britain, which has already approved the drug for early-stage treatment.
"Paxlovid is a promising oral antiviral drug but we don't know if it can improve survival of patients with severe Covid-19," said Peter Horby, a professor at the University of Oxford and joint chief investigator of the RECOVERY trial.
The scientists said they aim to mainly find whether Pfizer's Paxlovid reduces the risk of death among patients admitted to hospitals with Covid-19.
There are many reasons why people might need help with their dental problems. Maybe they don't have insurance, or maybe they just don't have the money to go to
a dentist. In these
cases, the pharmacy can be a great option. Pharmacists can provide a variety of services that can help people with their dental problems, including over-the-counter
medications and advice on how to take care of teeth and gums. In this blog post, we will discuss some of the ways that pharmacies can help you take care of your
teeth! So, whether you have a toothache, cavities, or bad breath, a pharmacy can be a great place to turn.
1) OVER-COUNTER MEDICATIONS
One of the most common services that pharmacies provide is the sale of over-the-counter medications. These medications are designed to be taken for short periods of
time and can help with a variety of dental problems. For example, if you have a toothache, you can buy an antiseptic rinse or analgesic gel that can help relieve
the pain. If you have bad breath, you can buy mouthwash or breath fresheners that will help mask the odor. And if you have cavities, you can purchase fluoride
rinses or gels that can help with decay prevention. If you are worried about the cost of dentists, these medications can be a great way to get the relief you need
without breaking the bank. However, it doesn't mean that you should neglect regular dental visits!
2) PROVIDE YOU WITH EDUCATION
Another way pharmacy can help you with your dental problems is through advice and education. Pharmacists are trained to provide general information on oral hygiene
and health and can help you make educated decisions about which products to buy. They can also provide recommendations on how often you should brush and floss your
teeth, as well as advice on diet and lifestyle choices that can help prevent dental problems. In addition, some pharmacies may even have an oral health specialist
on staff who can answer any questions you might have about your teeth or gums
Oral Care in Saudi Arabia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.
Human growth hormone is a significant growth hormone that is connected with many body functions. In the young age, this hormone is produced in surplus amount that starts decreasing after the age of thirty. Its deficiency causes many problems in the body that include low energy levels, disturbed immune system, weak muscles, and many other problems. Numbers of treatments are available to cure the deficiency that include injections, supplement, oral human growth hormone, and many therapies